Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.


Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 13 09 2018
revised: 13 01 2019
accepted: 16 01 2019
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 23 4 2019
Statut: ppublish

Résumé

Exposures to perfluoroalkyl substances (PFAS) including perfluoroalkyl acids (PFAAs) are associated with increased liver enzymes in cohort studies including the C8 Health Study. In animal models, PFAAs disrupt hepatic lipid metabolism and induce apoptosis to cause nonalcoholic fatty liver disease (NAFLD). PFAAs are immunotoxic and inhibit pro-inflammatory cytokine release from stimulated leukocytes in vitro. This cross-sectional study tests the hypothesis that environmental PFAAs are associated with increased hepatocyte apoptosis and decreased pro-inflammatory cytokines in serum. Biomarkers previously associated with PFAS exposures and/or NAFLD were evaluated as secondary endpoints. Two hundred adult C8 Health Study participants were included. Measured serum biomarkers included: perfluorohexane sulfonate (PFHxS); perfluorooctanoic acid (PFOA); perfluorooctane sulfonate (PFOS); perfluorononanoic acid (PFNA); cytokeratin 18 M30 (CK18 M30, hepatocyte apoptosis); adipocytokines; insulin; and cleaved complement 3 (C3a). Confounder-adjusted linear regression models determined associations between PFAS and disease biomarkers with cut-offs determined by classification and regression tree analysis. CK18 M30 was positively associated with PFHxS (β = 0.889, p = 0.042); PFOA (β = 2.1, p = 0.005); and PFNA (β = 0.567, p = 0.03). Tumor necrosis factor α (TNFα) was inversely associated with PFHxS (β = -0.799, p = 0.001); PFOA (β = - 1.242, p = 0.001); and PFOS (β = -0.704, p < 0.001). Interleukin 8 was inversely associated with PFOS and PFNA. PFAAs were also associated with sexually dimorphic adipocytokine and C3a responses. Overall, PFAA exposures were associated with the novel combination of increased biomarkers of hepatocyte apoptosis and decreased serum TNFα. These data support previous findings from cohorts and experimental systems that PFAAs may cause liver injury while downregulated some aspects of the immune response. Further studies of PFAAs in NAFLD are warranted and should evaluate sex differences.

Identifiants

pubmed: 30823334
pii: S0269-7491(18)34159-9
doi: 10.1016/j.envpol.2019.01.064
pmc: PMC6404528
mid: NIHMS1521335
pii:
doi:

Substances chimiques

Adipokines 0
Biomarkers 0
Fluorocarbons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1063

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM113226
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA024337
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES028373
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES023716
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES011564
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104942
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 May 25;819(2):329-38
pubmed: 15833298
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Toxicol Appl Pharmacol. 2009 Mar 1;235(2):182-90
pubmed: 19135466
Hepatology. 2009 Oct;50(4):1072-8
pubmed: 19585618
Am J Epidemiol. 2009 Nov 15;170(10):1268-78
pubmed: 19846564
Hepatology. 2010 Feb;51(2):474-81
pubmed: 19902480
Am J Gastroenterol. 2010 Jun;105(6):1354-63
pubmed: 20010922
Environ Health Perspect. 2009 Dec;117(12):1873-82
pubmed: 20049206
Environ Health Perspect. 2010 Feb;118(2):229-33
pubmed: 20123605
Environ Health Perspect. 2010 Feb;118(2):197-202
pubmed: 20123614
Arch Pediatr Adolesc Med. 2010 Sep;164(9):860-9
pubmed: 20819969
J Toxicol Sci. 2011 Apr;36(2):201-10
pubmed: 21467747
Toxicol Sci. 2011 Sep;123(1):290-303
pubmed: 21705711
Toxicology. 2011 Oct 9;288(1-3):8-17
pubmed: 21723365
J Occup Environ Med. 2011 Oct;53(10):1128-33
pubmed: 21915069
Toxicol Pathol. 2012;40(2):300-11
pubmed: 22109712
Environ Health Perspect. 2012 May;120(5):655-60
pubmed: 22289616
Environ Health Perspect. 2012 May;120(5):668-73
pubmed: 22306490
Biochim Biophys Acta. 2012 Jul;1820(7):1092-101
pubmed: 22484034
Toxicol Pathol. 2013 Feb;41(2):343-60
pubmed: 23262638
J Occup Health. 2013;55(3):184-94
pubmed: 23574777
PLoS One. 2013 Apr 23;8(4):e61409
pubmed: 23626681
Sci Rep. 2013;3:2174
pubmed: 23846197
Environ Int. 2013 Sep;59:354-62
pubmed: 23892228
J Pharm Biomed Anal. 2013 Dec;86:56-64
pubmed: 23978341
Chemosphere. 2014 Mar;98:78-83
pubmed: 24238303
Toxicol Lett. 2014 Oct 15;230(2):263-70
pubmed: 24503008
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):380-90
pubmed: 24998970
Chemosphere. 2015 Jun;129:225-31
pubmed: 25108893
Toxicol Pathol. 2015 Jun;43(4):546-57
pubmed: 25326589
Environ Res. 2015 Jan;136:8-14
pubmed: 25460614
Toxicology. 2015 Jul 3;333:53-62
pubmed: 25868421
Environ Health. 2015 Sep 29;14:79
pubmed: 26420011
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Toxicol Appl Pharmacol. 2016 Mar 15;295:85-93
pubmed: 26844784
Toxicol Rep. 2016;3:46-54
pubmed: 26942110
Biochim Biophys Acta. 2016 Sep;1859(9):1083-1099
pubmed: 26962021
Environ Health Perspect. 2016 Aug;124(8):1227-33
pubmed: 26978841
Chemosphere. 2016 Sep;159:166-177
pubmed: 27289203
Toxicol Sci. 2016 Sep;153(1):186-97
pubmed: 27413108
Environ Health Perspect. 2017 Mar;125(3):481-487
pubmed: 27586368
Reprod Toxicol. 2017 Mar;68:3-33
pubmed: 27760374
Toxicology. 2017 Mar 01;378:37-52
pubmed: 28049043
J Agric Food Chem. 2017 Jan 25;65(3):533-543
pubmed: 28052194
Biomed Res Int. 2017;2017:9729107
pubmed: 28326329
Environ Res. 2017 Jul;156:175-182
pubmed: 28349882
Toxicology. 2017 Jul 15;387:95-107
pubmed: 28558994
Environ Int. 2017 Sep;106:135-143
pubmed: 28645013
Pediatr Obes. 2018 Jun;13(6):342-347
pubmed: 28730729
Toxicol Rep. 2016 Aug 29;3:664-672
pubmed: 28959590
Cytotechnology. 2018 Feb;70(1):479-487
pubmed: 29335808
Hepatol Commun. 2018 Feb 09;2(3):270-284
pubmed: 29507902
Toxicol Sci. 2018 Jul 1;164(1):39-49
pubmed: 29684222
Environ Int. 2018 Aug;117:196-203
pubmed: 29754000
J Environ Manage. 2018 Sep 15;222:122-131
pubmed: 29807261
J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147
pubmed: 30470793

Auteurs

John Bassler (J)

Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, 26506, USA.

Alan Ducatman (A)

Department of Occupational and Environmental Health, West Virginia University School of Public Health, Morgantown, WV, 26506, USA.

Meenal Elliott (M)

Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, Morgantown, WV, 26506, USA.

Sijin Wen (S)

Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, 26506, USA.

Banrida Wahlang (B)

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville School of Medicine, Louisville, KY, 40202, USA.

John Barnett (J)

Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, Morgantown, WV, 26506, USA.

Matthew C Cave (MC)

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville School of Medicine, Louisville, KY, 40202, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, 40202, USA; Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, 40202, USA. Electronic address: matt.cave@louisville.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH